<!DOCTYPE html>
<html>
<head>
  <title>Bayesian Clinical Trials</title>

  <meta charset="utf-8">
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta http-equiv="X-UA-Compatible" content="chrome=1">
  <meta name="generator" content="pandoc" />




  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <meta name="apple-mobile-web-app-capable" content="yes">

  <link rel="stylesheet" media="all" href="index_files/ioslides-13.5.1/fonts/fonts.css">

  <link rel="stylesheet" media="all" href="index_files/ioslides-13.5.1/theme/css/default.css">
  <link rel="stylesheet" media="only screen and (max-device-width: 480px)" href="index_files/ioslides-13.5.1/theme/css/phone.css">

  <base target="_blank">

  <script type="text/javascript">
    var SLIDE_CONFIG = {
      // Slide settings
      settings: {
                title: 'Bayesian Clinical Trials',
                        subtitle: 'Real data case study',
                useBuilds: true,
        usePrettify: true,
        enableSlideAreas: true,
        enableTouch: true,
                favIcon: 'index_files/logo.png',
              },

      // Author information
      presenters: [
            ]
    };
  </script>

  <style type="text/css">

    b, strong {
      font-weight: bold;
    }

    em {
      font-style: italic;
    }

    slides > slide {
      -webkit-transition: all 0.4s ease-in-out;
      -moz-transition: all 0.4s ease-in-out;
      -o-transition: all 0.4s ease-in-out;
      transition: all 0.4s ease-in-out;
    }

    .auto-fadein {
      -webkit-transition: opacity 0.6s ease-in;
      -webkit-transition-delay: 0.4s;
      -moz-transition: opacity 0.6s ease-in 0.4s;
      -o-transition: opacity 0.6s ease-in 0.4s;
      transition: opacity 0.6s ease-in 0.4s;
      opacity: 0;
    }

    slides > slide:not(.nobackground):before {
      font-size: 12pt;
      content: "";
      position: absolute;
      bottom: 20px;
      left: 60px;
      background: url(index_files/logo.png) no-repeat 0 50%;
      -webkit-background-size: 30px 30px;
      -moz-background-size: 30px 30px;
      -o-background-size: 30px 30px;
      background-size: 30px 30px;
      padding-left: 40px;
      height: 30px;
      line-height: 1.9;
    }
  </style>

  <link rel="stylesheet" href="assets\css\ioslides.css" type="text/css" />


</head>

<body style="opacity: 0">

<slides class="layout-widescreen">

  <slide class="title-slide segue nobackground">
        <aside class="gdbar"><img src="index_files/logo.png"></aside>
        <!-- The content of this hgroup is replaced programmatically through the slide_config.json. -->
    <hgroup class="auto-fadein">
      <h1 data-config-title><!-- populated from slide_config.json --></h1>
      <h2 data-config-subtitle><!-- populated from slide_config.json --></h2>
      <p data-config-presenter><!-- populated from slide_config.json --></p>
          </hgroup>
  </slide>

<slide class=''><hgroup><h2>Case Study (Chiappella et al, 2013)</h2></hgroup><article  id="case-study-chiappella-et-al-2013">

<ul>
<li>Primary endpoint: to determine the maximum tolerated dose (MTD) of lenalidomide given in combination with fixed doses of R-CHOP in elderly patients with untreated DLBCL.</li>
</ul>

<center>

<img src='images/figure1.jpg' title=''/>

<center>

</article></slide><slide class=''><hgroup><h2></h2></hgroup><article >

<ul>
<li>\(d_{start}\) = 10 mg/day</li>
<li>DLT definition: the maximum dose inducing any grade \(\ge 3\) non-hematologic toxicity or a delay &gt;15 days of a planned cycle date observed during the first two cycles</li>
<li><p>TTL=33%</p></li>
<li>dose levels: 5, <em>10</em>, 15, 20 mg/day</li>
<li>CRM</li>
<li><p>cohort size: 3</p></li>
</ul>

</article></slide><slide class=''><hgroup><h2>CRM</h2></hgroup><article  id="crm">

<p>One parameter logistic model \[ 
P\left(Y=1|x_{i}\right)=\psi\left(x_{i},\theta\right)=\frac{exp\left(a_{0}+\theta x_{i}\right)}{1+exp\left(a_{0}+\theta x_{i}\right)}
\] where</p>

<ul>
<li>\(Y_{j}\) is the binary variable indicating toxicity for the \(j-th\) patient</li>
<li>\(x_{i}=\psi^{-1}\left(p_{i},\theta\right)\) is the standardized dose level</li>
<li>\(p_{i}\) the initial guesses of toxicity probability (i.e. \(p_{1}\)=0.15, \(p_{2}\)=0.20, \(p_{3}\)=0.25, and \(p_{4}\)=0.30)</li>
<li>\(a_{0}\) is the intercept</li>
<li>\(\theta\) is to be estimated.</li>
</ul>

</article></slide><slide class=''><hgroup><h2>Steps</h2></hgroup><article  id="steps">

<ul>
<li>choose a prior \(\pi\left(\theta\right)\) for \(\theta\)</li>
<li>starting from \(d_{start}\), compute sequentially, every after <em>c</em> patients (i.e. 3), the Bayesian posterior mean of the model parameter, \(\tilde{\theta_{j}}\) as</li>
</ul>

<p>\[
E\left(\theta_{j}|data\right)=\int_0^\infty \theta f\left(\theta|data\right) d\theta
\] where \(f\left(\theta|data\right)\) is the posterior density:</p>

<p>\[
f\left(\theta|data\right)=\frac{L_{j}\left(\theta\right)\pi\left(\theta\right)}{\int_0^\infty L_{j}\left(u\right)\pi\left(u\right) du}
\]</p>

</article></slide><slide class=''><hgroup><h2></h2></hgroup><article >

<ul>
<li>compute \(\psi\left(x_{i},\tilde{\theta}_{c}\right)\) and the next 3 patients will be assigned to the (standardized) dose level, that minimizes the distance \[\left|\psi\left(x_{i},\tilde{\theta}_{c}\right)-TTL\right|\]</li>
<li>after inclusion of <em>m</em> patients, the estimated probability of toxicity for the recommended dose level (at that point!), \(x_{R}\), will be \(\tilde{P}_{R|m}=\psi\left(x_{R},\tilde{\theta}_{m}\right)\)</li>
<li>a 1-\(\alpha\) credibility interval for \(P_{R|m}\) is \(\left(\theta_{min};\theta_{max}\right)\) where<br/>\[ 
\int_{\theta_{min}}^{\theta_{max}} f\left(\theta|data\right) d\theta=1-\alpha 
\]</li>
<li>stop when the maximum sample size has been reached (i.e. <em>n</em>=24) or stopping rules have been fulfilled</li>
</ul>

</article></slide><slide class=''><hgroup><h2>Stopping rules (Zohar &amp; Chevret, 2001)</h2></hgroup><article  id="stopping-rules-zohar-chevret-2001">

<p>Rules based on posterior distribution \[
\begin{align}
          &amp; w_{1} = P\left[ \psi\left(x_{first},\tilde{\theta} \right)&gt;TTL|data \right] \\
          &amp; w_{2} = P\left[ \psi\left(x_{last},\tilde{\theta} \right)&lt;TTL|data \right] 
\end{align}
\]</p>

<p>\(=&gt;\) stop for wrong dose scale if \(w_{1}&gt;0.9\) or \(w_{2}&gt;0.9\)</p>

</article></slide><slide class=''><hgroup><h2>Stopping rules (Zohar &amp; Chevret, 2001)</h2></hgroup><article  id="stopping-rules-zohar-chevret-2001-1">

<p>Rules based on predictive distribution of <em>z</em> future responses \[
\begin{align}
          &amp; w_{3} = \tilde{P}\left[ X\left(j+1\right)=...X\left(j+z\right)|data \right] \\
          &amp; w_{4} = \sum_{y_{1}=0}^{1}...\sum_{y_{z}=0}^{1}\left|\tilde{P}_{R|_{j+z}}-\tilde{P}_{R|_{j+1}}\right|P\left(Y_{j+1}=y_{1},...,Y_{j+z}=y_{z} |data \right) \\
          &amp; w_{5} = \max_\left(y_{1},...,y_{z}\right)  \left|\tilde{P}_{R|_{j+z}}-\tilde{P}_{R|_{j+1}}\right| 
\end{align}
\]</p>

<p>\(=&gt;\) stop for futility if \(w_{3}&gt;0.9\)</p>

<p>\(=&gt;\) stop for no mean predictive or no maximal predictive gain in point estimate of the estimated probability of toxicity if \(w_{4}&lt;0.05\) or \(w_{5}&lt;0.05\), respectively</p>

</article></slide><slide class=''><hgroup><h2></h2></hgroup><article >

<p>\[
\begin{align}
          &amp; w_{6} = \sum_{y_{1}=0}^{1}..\sum_{y_{z}=0}^{1}\left|c_{\alpha,j+z}\left(P_{R}\right)-c_{\alpha,j+1}\left(P_{R}\right)\right|P\left(Y_{j+1}=y_{1},..,Y_{j+z}=y_{z} |data \right) \\
          &amp; w_{7} = \max_\left(y_{1},...,y_{z}\right)\left| c_{\alpha,j+z}\left(P_{R}\right)-c_{\alpha,j+1}\left(P_{R}\right)\right|
\end{align}
\] where \(c_{\alpha,.}\left(P_{R}\right)\) is the width of the 100(1-\(\alpha\)) credibility interval of the toxicity probability at the recommended dose level \(d_{R}\).</p>

<p>\(=&gt;\) stop for no gain in accuracy of the estimated probability of toxicity if \(w_{6}&lt;0.05\) or \(w_{7}&lt;0.05\)</p>

</article></slide><slide class=''><hgroup><h2>Data</h2></hgroup><article  id="data">

<table class = 'rmdtable'>
<tr class="header">
<th align="left">Cohort</th>
<th align="left">Administered dose</th>
<th align="left">Toxicity</th>
<th align="left">dose 5 mg/day</th>
<th align="left">dose 10 mg/day</th>
<th align="left">dose 15 mg/day</th>
<th align="left">dose 20 mg/day</th>
</tr>
<tr class="odd">
<td align="left">1</td>
<td align="left">10</td>
<td align="left">(0,0,0)</td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
</tr>
<tr class="even">
<td align="left">2</td>
<td align="left">20</td>
<td align="left">(1,1,0)</td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
</tr>
<tr class="odd">
<td align="left">3</td>
<td align="left">15</td>
<td align="left">(0,0,1)</td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
</tr>
<tr class="even">
<td align="left">4</td>
<td align="left">15</td>
<td align="left">(1,0,0)</td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
</tr>
<tr class="odd">
<td align="left">5</td>
<td align="left">15</td>
<td align="left">(1,1,0)</td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
</tr>
<tr class="even">
<td align="left">6</td>
<td align="left">10</td>
<td align="left">(0,0,1)</td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
</tr>
<tr class="odd">
<td align="left">7</td>
<td align="left">10</td>
<td align="left">(0,0,0)</td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
<td align="left"></td>
</tr>
</table>

</article></slide><slide class=''><hgroup><h2>bcrm package</h2></hgroup><article  id="bcrm-package">

<p>bcrm implements a Bayesian CRM (O&#39;Quigley et al, 1990) and can run interactively, allowing the user to enter outcomes after each cohort has been recruited.</p>

<pre class = 'prettyprint lang-r'>library(bcrm)</pre>

<ul>
<li>Binary toxicity outcome</li>
<li>Dose-toxicity models: Hyperbolic Tangent, Logistic (1-and 2-parameter) and Power</li>
<li>Priors: Gamma, Uniform, Lognormal and Bivariate Lognormal</li>
<li>Stopping rules: maximum sample size, minimum sample size in conjuction with precision of the MTD or maximum number treated ad MTD</li>
</ul>

</article></slide><slide class=''><hgroup><h2>R code</h2></hgroup><article  id="r-code">

<pre class = 'prettyprint lang-r'>dose = c(5, 10, 15, 20)
p.tox0 = c(0.15, 0.20, 0.25, 0.3)
data = data.frame(patient=1:3, dose=rep(2,3), tox=rep(0,3))
target.tox = 0.33
bcrm(stop = list(nmax=24, precision=c(0.16,0.6)), 
     data = data, 
     p.tox0 = p.tox0, 
     dose = dose, 
     ff = &quot;logit1&quot;,
     prior.alpha = list(3, a=1, b=0.75),
     target.tox = target.tox,
     sdose.calculate = &quot;mean&quot;,
     constrain = FALSE
     )</pre>

</article></slide><slide class=''><hgroup><h2>References</h2></hgroup><article  id="references">

<ul>
<li><p>Chiappella A, Tucci A, Castellino A et al. Lenalidomide plus cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab is safe and effective in untreated, elderly patients with diffuse large B-cell lymphoma: a phase I study by the Fondazione Italiana Linfomi. Haematologica 2013; 98(11): 1732-1738.</p></li>
<li><p>Zohar S, Chevret S. The continual reassessment method: comparison of Bayesian stopping rules for dose-ranging studies. Stat Med 2001; 20: 2827-2843.</p></li>
<li><p>O&#39;Quigley J, Pepe M, Fisher L. Continual reassessment method: a practical design for phase I clinical trials in cancer. Biometrics 1990; 46: 33-48.</p></li>
</ul>

</article></slide><slide class=''><hgroup><h2>prova</h2></hgroup><article  id="prova">

<p>\[
\begin{table}
    \begin{tabular}{llllll}
    Cohort &amp; Toxicity &amp; dose 5 mg/day &amp; dose 10 mg/day &amp; dose 15 mg/day &amp; dose 20 mg/day \\
    1      &amp; (0,0,0)  &amp; ~             &amp; ~              &amp; ~              &amp; ~              \\
    2      &amp; (1,1,0)  &amp; ~             &amp; ~              &amp; ~              &amp; ~              \\
    3      &amp; (0,0,1)  &amp; ~             &amp; ~              &amp; ~              &amp; ~              \\
    4      &amp; (1,0,0)  &amp; ~             &amp; ~              &amp; ~              &amp; ~              \\
    5      &amp; (1,1,0)  &amp; ~             &amp; ~              &amp; ~              &amp; ~              \\
    6      &amp; (0,0,1)  &amp; ~             &amp; ~              &amp; ~              &amp; ~              \\
    7      &amp; (0,0,0)  &amp; ~             &amp; ~              &amp; ~              &amp; ~              \\
    \end{tabular}
\end{table}
\]</p></article></slide>


  <slide class="backdrop"></slide>

</slides>

<script src="index_files/ioslides-13.5.1/js/modernizr.custom.45394.js"></script>
<script src="index_files/ioslides-13.5.1/js/prettify/prettify.js"></script>
<script src="index_files/ioslides-13.5.1/js/prettify/lang-r.js"></script>
<script src="index_files/ioslides-13.5.1/js/prettify/lang-yaml.js"></script>
<script src="index_files/ioslides-13.5.1/js/hammer.js"></script>
<script src="index_files/ioslides-13.5.1/js/slide-controller.js"></script>
<script src="index_files/ioslides-13.5.1/js/slide-deck.js"></script>

<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "index_files/mathjax-local/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

<!-- map slide visiblity events into shiny -->
<script>
  (function() {
    if (window.jQuery) {
       window.jQuery(document).on('slideleave', function(e) {
         window.jQuery(e.target).trigger('hidden');
      });
       window.jQuery(document).on('slideenter', function(e) {
         window.jQuery(e.target).trigger('shown');
      });
    }
  })();
</script>

</body>
</html>
